Wednesday, April 27, 2005
"A federal judge has granted final approval to SmithKline Beecham's $65 million settlement of a class action antitrust suit brought by consumers who said they paid inflated prices for Paxil, a popular anti-depressant drug.
"The suit alleged that SmithKline illegally maintained a monopoly by filing a series of "sham" patent lawsuits that were designed to delay any generic version of the drug from reaching the market."
Monday, April 25, 2005
CVS settles an antitrust suit brought by the DC government challenging its purchase and closing of a local pharmacy as a monopolistic practice. The settlement of $ 475,000 "will be divided between the District's antitrust enforcement fund, which will receive $125,000, and a charity to be designated by the attorney general, which will receive $350,000 to help low-income D.C. residents purchase prescription drugs."